comparemela.com
Home
Live Updates
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2023 Earnings Call Transcript : comparemela.com
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for attending the Jazz Pharmaceuticals Second Quarter 2023 Financial Results Call. My name is Elissa, and I will be your moderator for today's call.
Related Keywords
United States
,
American
,
America
,
Marc Goodman
,
Andrea Flynn
,
Jason Gerberry
,
Kim Sablich
,
Rob Iannone
,
Bruce Cozadd
,
Dan Swisher
,
Joseph Thome
,
American Heart Association
,
Nasdaq
,
Most Profitable Pharmaceutical Companies
,
European Commission
,
European Society Of Medical Oncology
,
American Academy Of Neurology Meeting
,
Jazz Pharmaceuticals Plc
,
Jazz Pharmaceuticals Second Quarter
,
Jazz Pharmaceuticals
,
Call Transcript August
,
Chief Executive Officer
,
Renee Gala
,
Executive Vice President
,
Chief Financial Officer
,
Chief Operating Officer
,
Global Head
,
General Manager
,
American Academy
,
Neurology Meeting
,
Profitable Pharmaceutical Companies In The World
,
European Society
,
Medical Oncology
,
Plastics Stocks To Buy
,
comparemela.com © 2020. All Rights Reserved.